Pediatric Transplant and Oncology Infectious Diseases
Antimicrobial stewardship in immunocompromised hosts
Publication
, Chapter
Wolf, J; Gerber, JS; Smith, MJ
January 1, 2020
Antimicrobial stewardship refers to the appropriate selection, dosing, route, and duration of antimicrobial therapy to optimize patient outcomes and minimize toxicity and the development of resistant pathogens. The optimal stewardship strategies in the pediatric immunocompromised host are not well defined. In this chapter, we review the goals of antimicrobial stewardship in the immunocompromised host, discuss barriers to implementation, and offer specific stewardship strategies that may be useful in this population.
Duke Scholars
DOI
ISBN
9780323641982
Publication Date
January 1, 2020
Start / End Page
78 / 81.e3
Citation
APA
Chicago
ICMJE
MLA
NLM
Wolf, J., Gerber, J. S., & Smith, M. J. (2020). Antimicrobial stewardship in immunocompromised hosts. In Pediatric Transplant and Oncology Infectious Diseases (pp. 78-81.e3). https://doi.org/10.1016/B978-0-323-64198-2.00020-8
Wolf, J., J. S. Gerber, and M. J. Smith. “Antimicrobial stewardship in immunocompromised hosts.” In Pediatric Transplant and Oncology Infectious Diseases, 78-81.e3, 2020. https://doi.org/10.1016/B978-0-323-64198-2.00020-8.
Wolf J, Gerber JS, Smith MJ. Antimicrobial stewardship in immunocompromised hosts. In: Pediatric Transplant and Oncology Infectious Diseases. 2020. p. 78-81.e3.
Wolf, J., et al. “Antimicrobial stewardship in immunocompromised hosts.” Pediatric Transplant and Oncology Infectious Diseases, 2020, pp. 78-81.e3. Scopus, doi:10.1016/B978-0-323-64198-2.00020-8.
Wolf J, Gerber JS, Smith MJ. Antimicrobial stewardship in immunocompromised hosts. Pediatric Transplant and Oncology Infectious Diseases. 2020. p. 78-81.e3.
DOI
ISBN
9780323641982
Publication Date
January 1, 2020
Start / End Page
78 / 81.e3